AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 19 filers reported holding AC IMMUNE SA in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $43,623 | -42.6% | 21,384 | +39.5% | 0.00% | -100.0% |
Q4 2021 | $76,000 | -73.2% | 15,327 | -63.8% | 0.00% | -75.0% |
Q3 2021 | $284,000 | +456.9% | 42,319 | +556.5% | 0.00% | +300.0% |
Q2 2021 | $51,000 | -12.1% | 6,446 | -38.0% | 0.00% | 0.0% |
Q2 2019 | $58,000 | -68.6% | 10,397 | -7.4% | 0.00% | -91.7% |
Q3 2016 | $185,000 | – | 11,222 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 11,297,911 | $55,925,000 | 5.88% |
Prosight Management, LP | 1,248,453 | $6,180,000 | 3.43% |
PA Capital LLC | 76,257 | $377,000 | 0.37% |
Artal Group S.A. | 1,000,000 | $4,950,000 | 0.20% |
Temasek Holdings (Private) Ltd | 2,614,095 | $12,940,000 | 0.10% |
COHEN LAWRENCE B | 13,350 | $66,000 | 0.04% |
Tekla Capital Management LLC | 171,813 | $850,000 | 0.04% |
Athanor Capital, LP | 108,540 | $537,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 28,600 | $142,000 | 0.02% |
APPLETON PARTNERS INC/MA | 11,525 | $57,000 | 0.01% |